Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin
Publication
, Conference
Krasuski, RA; Smith, B; Carey, S; Galbreath, AD; Stajduhar, KC; Kwan, MD; Ellis, R; Freeman, GL
Published in: EUROPEAN HEART JOURNAL
September 1, 2005
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
September 1, 2005
Volume
26
Start / End Page
411 / 411
Location
Stockholm, SWEDEN
Publisher
OXFORD UNIV PRESS
Conference Name
27th Congress of the European-Society-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Krasuski, R. A., Smith, B., Carey, S., Galbreath, A. D., Stajduhar, K. C., Kwan, M. D., … Freeman, G. L. (2005). Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin. In EUROPEAN HEART JOURNAL (Vol. 26, pp. 411–411). Stockholm, SWEDEN: OXFORD UNIV PRESS.
Krasuski, R. A., B. Smith, S. Carey, A. D. Galbreath, K. C. Stajduhar, M. D. Kwan, R. Ellis, and G. L. Freeman. “Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin.” In EUROPEAN HEART JOURNAL, 26:411–411. OXFORD UNIV PRESS, 2005.
Krasuski RA, Smith B, Carey S, Galbreath AD, Stajduhar KC, Kwan MD, et al. Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2005. p. 411–411.
Krasuski, R. A., et al. “Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin.” EUROPEAN HEART JOURNAL, vol. 26, OXFORD UNIV PRESS, 2005, pp. 411–411.
Krasuski RA, Smith B, Carey S, Galbreath AD, Stajduhar KC, Kwan MD, Ellis R, Freeman GL. Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2005. p. 411–411.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
September 1, 2005
Volume
26
Start / End Page
411 / 411
Location
Stockholm, SWEDEN
Publisher
OXFORD UNIV PRESS
Conference Name
27th Congress of the European-Society-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology